RPRX — Royalty Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual balance sheet for Royalty Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	793	2,649	2,803	2,428	1,234
Net Total Accounts Receivable
Net Total Receivables	38.8	39.2	68.3	36.6	36.6
Total Other Current Assets
Total Current Assets	832	2,697	2,878	2,555	1,274
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	12,450	16,020	17,516	16,813	16,382
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	333	308	171	1,167	161
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	6,344	11,202	11,739	11,185	9,855
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	6,106	4,819	5,777	5,628	6,526
Total Liabilities & Shareholders' Equity	12,450	16,020	17,516	16,813	16,382
Total Common Shares Outstanding